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Abstract
Background: Studies evaluating the role of both corticosteroids and platelet-rich plasma (PRP) in the treatment of
rotator cuff (RC) tendinopathies have been contradicting.
We compared structural and clinical changes in RC muscles after corticosteroids and PRP injections.
Methods: This is a randomized double-blind clinical trial. All individuals with diagnosis of RC tendinitis during
2014–2017 were considered. Individuals were randomly allocated to either receive PRP or corticosteroids.
Overall, 3cc of PRP was injected within the subacromial joint and another 3cc was injected at the site of the tendon
tear, under the guide of sonography. For the corticosteroid group, 1cc of Depo-medrol 40mg and 1cc of lidocaine
(2%) was injected within the subacromial joint.
Results: Overall, 58 patients entered the study. Comparison of pain, range of motion (ROM), Western Ontario RC
(WORC), Disability of Arm-Hand-Shoulder (DASH) scores, and supraspinatus thickness showed significant
improvement during follow-ups in both groups (p<0.05).
During 3 months of follow-up, pain improvement was significantly better within the PRP group during (from 6.66±
2.26 to 3.08±2.14 and 5.53±1.80 to 3.88±1.99, respectively; p=0.023). Regarding ROM, the PRP group had significant
improvement in adduction (20.50°±8.23° to 28°±3.61° and 23.21°±7.09° to 28.46°±4.18° for the PRP and corticosteroid
groups, respectively; p=0.011) and external rotation (59.66°±23.81° to 76.66°±18.30° and 57.14°±24.69° to 65.57°±26.39°,
for the PRP and corticosteroid groups, respectively; p=0.036) compared to the corticosteroid group.
Conclusion: We found that PRP renders similar results to that of corticosteroids in most clinical aspects among
patients with RC tendinopathies; however, pain and ROM may show more significant improvement with the use of
PRP. Considering that the use of corticosteroids may be contraindicated in some patients and may be associated with
the risk of tendon rupture, we suggest the use of PRP in place of corticosteroid-based injections among patients with
RC tendinopathy.
Trial registration: Clinical trial registration code: IRCT201302174251N9
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Introduction
Shoulder pain is among the most common complaints
in medicine and disorders attributed to the RC are the
most common cause of shoulder pains [1]. More than
50% of all shoulder pains are considered to be that re-
lated to tendinopathies of the RC, as supraspinatus in-
complete thickness tears and tendinosis [2].
In clinical assessment of RC tendinopathies, rehabilita-
tion time can be lengthy as the healing ability of tendons
is limited; thus, treatment modalities have been intro-
duced that focus on the potential to induce more rapid
healing. Conventionally, physical rehabilitation, rest, and
nonsteroidal anti-inflammatory drugs (NSAIDs) are con-
sidered for a patient with RC tendinopathy as the first
line of treatment [3, 4]. If the patient does not respond
to these, the more commonly used treatment modality
for patients are sub-acromial injections of corticoste-
roids, which have been shown to be affective in acceler-
ating the healing process. Corticosteroids have been
more effective during the acute phase of tendinitis, al-
though they have been associated with risks of tendon
tear and may inhibit collagen synthesis [5, 6].
More recently, platelet-rich plasma (PRP) has been
recognized for its possible biological role by providing
cellular and humeral mediators which may improve the
healing process [7, 8].
Studies have been conducted in recent years evaluating
the role of both corticosteroids and PRP in the treat-
ment of tendinopathies related to the RC; however, these
studies have been somewhat contradicting as some have
found no difference between placebo controls and PRP
and corticosteroids and some have reported more rapid
benefits with PRP injections among patients [2, 8–10].
Moreover, almost all the aforementioned studies have
mainly focused on factors such as pain and functional
outcomes, so here, we aimed to evaluate the structural
changes in the muscles of the RC after corticosteroids in
comparison to PRP injections in the settings of a double
blind clinical trial study.
Patients and methods
Study settings and patients
This is a randomized double-blind clinical trial con-
ducted in the Hazrat Rasoul Hospital, Tehran, Iran. All
individuals who had a complaint of shoulder pain during
January 2014 to January 2017 were initially considered
for the study. Individuals who had tendinitis or incom-
plete tear of the RC tendons, which was confirmed with
MRI, had pain for more than 3 months, were older than
40 years old, and had a total of three positive tests out of
the following five tests: neer, speed, full can, empty can,
and the Hawkins test, were included in the study.
Those who were unwilling to enter the study or did
not refer for follow-ups, those who did not follow the
study protocol, had radicular pain, had signs of other
pathologies including frozen shoulders or calcified ten-
dinitis, those who had complete tear of RC tendons, had
surgery during the past 6 months, had inflammatory dis-
eases such as rheumatoid arthritis, fibromyalgia, poly-
myalgia rheumatica, and etc., had ligamentous laxity (a
positive apprehension test or sulcus test), and those who
had corticosteroid-based injections in the shoulder dur-
ing the past 3 months, were excluded from the study.
These individuals were randomly selected to enter the
study using simple random selection.
Randomization
Individuals were classified into two groups of PRP and
corticosteroid groups, using the permuted block
randomization method. All randomizations were done
by the Department of Sports Medicine at Iran University
of Medical Sciences, Tehran, Iran.
Study design
During visit at related clinics, complete medical history
on pain and specific data on functional problems of the
shoulder were acquired. After which complete examin-
ation of range of motion of shoulder, specific tests re-
lated to tendon function within the RC and shoulder
biceps were performed.
For evaluating the RC, each patient underwent MRI of
the shoulder for confirmation of tendinopathy of shoul-
der. Tendinitis was considered when signal of the ten-
don changed while tendon was preserved. Incomplete
tear of the tendon was considered a detachment of the
tendon without including the whole thickness of the
tendon.
Patients were then referred for ultrasonography. Tendons
of the shoulder were evaluated by a specialist in sports
medicine. Sonography was done using a Mindray M5
system (China) and by a 7L4s transducer.
All assessments were done by a single sports medicine
specialist who was blinded to the grouping of patients,
in order to minimize bias in measurements.
Definition of variables
For subjective evaluation of patients, the Western Ontario
RC (WORC) and Disability of Arm-Hand-Shoulder
(DASH) questionnaires were utilized. After detailed ex-
planation, each individual filled in the questionnaires.
The WORC questionnaire is a measure of functional
limitations in RC pathology. This index considers 5
variables in its assessment, including physical symp-
toms, physical activity, work, daily activity, and men-
tality and excitement. Each item is scored from 0 to
100, and the higher the score the worse the condition
of the shoulder [11].
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The DASH questionnaire is a measure of disability
and includes 30 questions which assess individuals’ abil-
ity to perform daily activity, for example: ability to carry
objects, writing, and other daily activities. Patients are
scored from 0 to 100 and a higher score indicates a
worse condition [12].
Pain was assessed using the Visual Analogue Scale
(VAS) questionnaire. In this system of scoring, a picture
is shown to the individual which is consequently scored
from 0 to 10. The higher the number, the higher the se-
verity of the pain [13].
Range of motion of shoulder was directly evaluated by
a manual medical Goniometer (Dahi Teb, Iran) [14].
Range of motion (ROM) of shoulder, abduction, adduc-
tion, forward flexion, internal and external rotation, and
extension were assessed according to the Kendall
method [13]. Measurement of ROM was done by one
trained expert in sports medicine. To reduce bias, all
ROM tests were performed three times and mean of
these measurement were considered for each individual.
Data on baseline characteristics, range of motion,
WORC score, DASH score, and VAS score was obtained
from each patient. The minimal detectable change
(MDC) for the WORC, DASH, and VAS is reported to
be 1.7 [15], 10.2 [16], and 0.08 [17], respectively, accord-
ing to previous literature.
Intervention
The PRP was prepared and processed in ROOYA GEN®
(Arya Mabna Tashkhis Co., Tehran, Iran). For the cor-
ticosteroid injections, the Depo-medrol 40mg (Pfizer
Inc., USA) was used.
For the administration of PRP or corticosteroid, pa-
tients were seated. After proper preparation, 3cc of PRP
was injected within the intraarticular joint and another
3cc of PRP was injected at the site of the tendon tear,
under guide of sonography [2].
For the corticosteroid group, 1cc of Depo-medrol
40mg and 1cc of lidocaine (2%) was injected within the
subacromial joint similar to the PRP group.
After the injections, patients were asked to withdraw
from using any non-steroidal anti-inflammatory drugs
(NSAID). In cases with pain, they were allowed to use
acetaminophen.
After the injections, both groups were given shoulder
exercise and scapula dyskinesia regimens. Patients were
blinded to the treatment groups and were unaware of
the type of injections received.
Follow-ups
Baseline information, medical history, and physical
examination of patients were recorded during first visit.
Patients were then visited 1 week, 1 month, and 3
months after administration of medication. In cases of
pain or any complaint patient were able to either contact
or refer to the sports clinic.
DASH and WORC scores were evaluated at baseline, 1
month, and 3 months post-intervention; however, other
parameters including ROM and VAS were evaluated at
five occasions of baseline, 1 week, 1 month, and 3
months post-intervention.
Thickness of the supraspinatus muscle was evaluated
at baseline, 1 month and 3 months of follow-up.
Allocation concealment
All follow-ups were done by a single specialist in sports
medicine who was blinded to the allocation of patients.
A clinical trial nurse was appointed to remove any infor-
mation from patients’ medical records prior to visitation
by the assessor.
Primary endpoint
Pain using the VAS score.
Secondary end points
(1) Range of motion, (2) supraspinatus thickness, (3)
WORC score, and (4) DASH score
Sample size calculation
Severity of pain, evaluated using the VAS questionnaire,
was considered the primary outcome of the study. Cor-
relation of VAS from beginning of the study to the end
point was 0.4 (r = 0.4). For obtaining a statistical differ-
ence of 13 or more, and considering a standard deviation
of 20 [13], type one error of 5% and a power of study of
80%, a minimum of 30 individuals were needed for each
of the study groups.
Ethical consideration
All participants gave their written and informed consent
to take part in the study. The study protocol was in
coherence with the guidelines of the Declaration of
Helsinki.
Statistical analysis
Data was analyzed using the SPSS software, for windows,
version 23. All dependent variables were tested by
Shapiro-Wilk test for normality. The assumption of nor-
mality was accepted when p value was >0.05. For com-
parison of qualitative data between groups, the chi-
sqaure test and for comparison of quantitative data with
normal distribution between two groups the independ-
ent t test was used. For comparison of scores during
follow-ups, the ANOVA test (GLM Repeated measures
test) was used.
A p value of less than 0.05 was considered statistically
significant.
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Results
In total, 58 patients entered the study. Two patients
were lost to follow-up after 3 months in the corticoster-
oid group.
Comparison of baseline characteristics and baseline
clinical assessment including ROM, WORC score,
DASH score, and supraspinatus thickness in US is
shown in Table 1.
Results showed that regarding baseline ROM assess-
ments, the PRP group had a more limited ROM in ex-
tension (35.16° ± 10.78° vs. 41.42° ± 10.87°, p = 0.017).
Moreover, the PRP group also showed higher degree of
pain in baseline assessments compared to the cortico-
steroid group (Table 1).
Comparison of pain, ROM, WORC, and DASH scores
and muscle thickness showed significant improvement
during follow-ups in both groups (p < 0.05).
Comparison of the two groups showed that changes in
pain was significantly higher within the PRP group com-
pared to the corticosteroid group during the 3-month
follow-up period (from 6.66 ± 2.26 to 3.08 ± 2.14 and
5.53 ± 1.80 to 3.88 ± 1.99, respectively; p = 0.023). Re-
garding ROM, the PRP group showed more significant
improvement in adduction (20.50° ± 8.23° to 28° ± 3.61°
and 23.21° ± 7.09° to 28.46° ± 4.18° for the PRP and cor-
ticosteroid groups, respectively; p = 0.011) and external
rotation (59.66° ± 23.81° to 76.66° ± 18.30° and 57.14° ±
24.69° to 65.57° ± 26.39°, for the PRP and corticosteroid
groups, respectively; p = 0.036) compared to the cortico-
steroid group.
The two groups did not show any difference in im-
provement of other measures of ROM, WORC score,
DASH score, and supraspinatus thickness during the
follow-up period (p > 0.05) (Table 2).
Discussion
In this study, we compared the results of two of the
most common treatment methods, PRP and corticoster-
oid injections, for those with tendinitis or incomplete
tear of RC tendons of the shoulder, in the settings of a
double blind clinical trial study. To the best of the au-
thors’ knowledge, this is the first time that ultrasonog-
raphy structural changes have been considered for
assessment after a combination of exercise and injection
of PRP or corticosteroids.
We found that those who received PRP injections
showed significant improvement in pain after three
months of follow-up compared to the corticosteroid
group. Regarding ROM, those who received PRP also
showed better improvement in adduction and external
rotation during our follow-up period.
Regarding muscle thickness, evaluated using ultrason-
ography, the two groups did not show any difference in
any of the follow-ups.
Despite biological justification for the clinical efficacy
of PRP use in the settings of tendinopathy, high level
evidence on the effects of PRP in tendinopathy is scarce
[18–20]. In a study by Scarpone et al. [21] evaluating the
effects of PRP among patient with RC tendinopathy re-
sistant to physical rehabilitation and corticosteroids, they
found that after injection of zilocain (1%) and 3.5ml of
PRP within the lesion, during a 52-week follow-up, func-
tional scores showed a significant improvement (at
weeks 8 and 12 of follow-up). Moreover, VAS score also
Table 1 Baseline and clinical characteristics of the PRP and corticosteroid groups
Variables Groups
PRP (n=30) Corticosteroid (n = 28) Overall p value
Age—years 57.33 ± 9.80 53.60 ± 7.24 55.53 ± 8.79 0.108
Sex—no. (%) 0.644
Male 5 (16.7) 6 (21.4) 11 (19)
Female 25 (83.3) 22 (78.6) 47 (81)
VAS score 6.66 ± 2.26 5.53 ± 1.80 6.14 ± 2.15 0.041
Flexion—degrees 116.90 ± 37.58 135.42 ± 35.70 126 ± 38.15 0.060
Extension—degrees 35.16 ± 10.78 41.42 ± 10.87 38.21 ± 10.19 0.017
Abduction—degrees 102.83 ± 36.07 118.46 ± 41.43 109.32 ± 39.50 0.130
Adduction—degrees 20.50 ± 8.23 23.21 ± 7.09 22.05 ± 7.73 0.186
Internal rotation—degrees 64.26 ± 17.06 60.17 ± 19.41 62.73 ± 18.26 0.397
External rotation—degrees 59.66 ± 23.81 57.14 ± 24.69 58.39 ± 24.49 0.694
WORC score 32.85 ± 19.43 35.56 ± 17.97 34.46 ± 18.81 0.585
DASH score 54.02 ± 18.24 52.50 ± 20.32 53.51 ± 1925 0.764
Supraspinatus thickness—mm 6.97 ± 1.46 7.47 ± 1.38 7.20 ± 1.43 0.354
PRP platelet-rich plasma, VAS Visual Analogue Scale, WORC Western Ontario Rotator Cuff, DASH Disability of Arm-Hand-Shoulder
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showed significant improvement at 12 and 52 weeks of
follow-up. Regarding ROM, they found the best im-
provement in external rotation at 12 weeks of follow-up
(p < 0.001).
Another study by Kesikburun et al. [9] compared the
effects of PRP injections with that of saline injection
(placebo) in a clinical trial study. They included a total
of 40 patients with tendinopathies of the RC and or with
partial tear of the RC. Participants had sub-acromial in-
jections of PRP under the guide of sonography. They
compared the two groups regarding WORC index, pain
(VAS), and quality of life, and they found no difference
between the two groups regarding any of the variables
during 1-year follow-ups. This study showed the inef-
fectiveness of PRP compared to a placebo control. This
was attributed to multiple factors including the effects of
exercise regimens and the needling processes which it-
self stimulates bleeding and the consequent tissue and
tendon repair.
On the other hand, another study by Wesner et al.
[22] found that patients receiving PRP showed better
function and reduced pain compared to a group that re-
ceived placebo during a 6-month follow-up. Moreover,
they also found that those who received PRP had better
improvement of RC in MRI findings, although those in
the placebo group did not show any significant change.
Von Wehren et al. [23] also compared autologous con-
ditioned plasma or ACP with the effects of corticoste-
roids among patients with partial symptomatic tear of
RC in 2016. They compared the two groups regarding
VAS, Simple Shoulder Test (SST), The American Shoul-
der and Elbow Surgeons Shoulder Score (ASES), and the
Constant-Murley Score (CMS). In their study, similar to
ours, they found that the ACP group (compared to the
corticosteroids group) had a better ASES, VAS, and
CMS after 12 weeks of follow-up compared to the base-
line. They did not find a significant difference between
the two groups in MRI findings.
In a study by Shams and colleagues in 2016 [2], they
compared the effects of PRP injections compared to that
of corticosteroid injections among patients with incom-
plete tear of RC tendons in the settings of a clinical trial
study. They found that after 6 months of follow-up,
those who receive PRP injections report less pain. How-
ever, they did not find a statistically significant difference
between the two groups regarding function and MRI
findings. We did find a significant improvement in pain,
although unlike the mentioned study, we did record a
significant improvement in range of motion after 3
months of follow-up in the PRP group.
Our study showed that both PRP and corticosteroid
injections can alter and improve function of the shoulder
in RC tendinopathies. However, during our 3-month
follow-up, the PRP group showed better improvement in
VAS index which is a specific measure of pain and in
ROM.
Although we should consider that our study showed
that most benefits of PRP compared to corticosteroids in
earlier follow-ups (3 months in our study), and perhaps
longer follow-ups, minimize the benefits of PRP injections
over corticosteroid injections, considering that the ROM
is more affected by exercise rather than injections of PRP
or corticosteroids. Our findings are similar to that of the
latter study as they concluded that perhaps ACPs show
their effects earlier than that of corticosteroids.
One of the interesting findings in our study was that
we did not document any change in the thickness of the
supraspinatus muscle over time in any of the groups.
This shows that perhaps improvement of function in the
shoulder is not necessarily associated with improvement
in imaging and paraclinical tests, and further studies
with longer follow-ups are needed to evaluate the rela-
tionship between paraclinical findings and functional im-
provement after intra articular injections.
This study was not without limitation. As this was a
clinical trial study, some individuals did not refer for
their follow-ups and were lost during the study. Our
study did not have a placebo control, which may have af-
fected our final results, although the main objective of
our study was to compare two of the most common in-
jectable medications used for tendinopathies. We only
had a single session of PRP injections, although some
studies have advised the injection of a second dose of
PRP one to 2 months from the initial injection of PRP
[9]. In our study, our corticosteroid group also received
one session of injection to increase homogeneity be-
tween groups.
Considering that some paraclinical changes including
muscle thickness may require more than 6 months to
show significant change and improvement, our follow-
up visit may have been short. Moreover, MRI provides a
more accurate tool for assessment of structural changes.
As the supraspinatous muscle is the most common
muscle involved in RC tendinopathy [24], we focused on
changes on this specific muscle.
Considering the limitations of current literature, we
propose future clinical trials to include a large sample
size and to consider factors such as the use of placebo
control and more injection sessions and even the use of
combination of medications as one recent study [8]
showed that the simultaneous use of both corticosteroids
and PRP may be possible as the two medications do not
interact.
Conclusion
We found that PRP renders similar results to that of
corticosteroids in most clinical aspects among patients
with RC tendinopathies; however, pain and ROM may
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show more significant improvement with the use of
PRP. Considering that the use of corticosteroids may be
contraindicated in some patients and may be associated
with the risk of tendon rupture, we suggest the use of
PRP in place of corticosteroid based injections among
patients with RC tendinopathy.
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